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Abstract: Alzheimer’s disease (AD) is the most common neurodegenerative disorder and the primary
form of dementia in the elderly. One of the main features of AD is the increase in amyloid-beta
(A ) peptide production and aggregation, leading to oxidative stress, neuroinflammation and
neurodegeneration. Polyphenols are well known for their antioxidant, anti-inflammatory and
neuroprotective effects and have been proposed as possible therapeutic agents against AD. Here,
we investigated the effects of a polyphenolic extract of Arabidopsis thaliana (a plant belonging to the
Brassicaceae family) on inflammatory response induced by A . BV2 murine microglia cells treated
with both A 25–35 peptide and extract showed a lower pro-inflammatory (IL-6, IL-1b, TNF-a) and
a higher anti-inflammatory (IL-4, IL-10, IL-13) cytokine production compared to cells treated with
A  only. The activation of the Nrf2-antioxidant response element signaling pathway in treated cells
resulted in the upregulation of heme oxygenase-1 mRNA and in an increase of NAD(P)H:quinone
oxidoreductase 1 activity. To establish whether the extract is also effective against A -induced
neurotoxicity in vivo, we evaluated its effect on the impaired climbing ability of AD Drosophila flies
expressing human A 1–42. Arabidopsis extract significantly restored the locomotor activity of these
flies, thus confirming its neuroprotective effects also in vivo. These results point to a protective effect
of the Arabidopsis extract in AD, and prompt its use as a model in studying the impact of complex
mixtures derived from plant-based food on neurodegenerative diseases.
Keywords: Arabidopsis thaliana; amyloid beta; polyphenols; Alzheimer’s disease; BV2 cells;
interleukins; Nrf2; NF-B
1. Introduction
Natural polyphenols, a vast group of compounds present in plant-based food, confers protection
against cancer, cardiovascular, metabolic and neurodegenerative diseases [1–4].
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The interest in polyphenols as possible therapeutic agents in neurodegenerative diseases stems
from the well-documented evidence of their antioxidant effects both in vitro and in vivo, as largely
studied in Alzheimer’s disease (AD) [5]. The complex neuropathology of AD is primarily characterized
by increased production of amyloid-  (A ) oligomeric species and extracellular deposition of fibrillary
A  peptides in the form of plaques, whose accumulation is a major cause of inflammation, oxidative
stress and mitochondrial dysfunction [6,7]. Among the various neuroprotective strategies against
A -mediated reactive oxygen species (ROS) damages and inflammation proposed in AD, polyphenols
represent an attractive therapeutic option [8].
Indeed, polyphenols may counteract neurodegenerative diseases with different mechanisms
at various levels. They exert antioxidant activity by inducing the expression of antioxidant
enzymes, as well as inhibiting the expression of pro-oxidant enzymes [9–11]. By modulating
intracellular signaling cascades and gene expression, and by interacting withmitochondria, they induce
morphological changes that have a direct positive influence on memory acquisition, consolidation
and storage. Moreover, polyphenols exert a remarkable anti-inflammatory activity by suppressing
the activation of microglia, and by affecting inflammatory redox signaling pathways via modulation
of pro-inflammatory gene expression, mainly acting through nuclear factor-kappaB (NF-B) and
mitogen-activated protein kinase signaling [9,12,13]. Furthermore, polyphenols may modulate A 
production and aggregation by stimulating ↵-secretase and by inhibiting  - and  -secretase, and by
competitively interacting with aromatic residues preventing the ⇡–⇡ interaction, thus blocking the
amyloid self-assembly process [14,15]. Some phenolics, such as quercetin and myricetin, are able to
inhibit the  -secretase enzyme interfering with the A  generation cascade, whereas other phenolics,
such as epigallocatechin gallate, curcumin, trans-resveratrol, or oleuropein, are able to inhibit amyloid
aggregation and fibrillogenesis [16]. A polyphenol rich extract of Hypericum was suggested to
positively affect A  clearance by activation of ABC transporters in the blood-brain-barrier [17–19].
Polyphenols have the capacity to influence gene expression by modulating epigenetic mechanisms
that have been associated with AD [20]. For instance, resveratrol is an indirect activator of SIRT-1,
an NAD+-dependent deacetylase found to be reduced in the cortex of patients with AD, whereas
curcumin was shown to inhibit both histone acetyl transferase and DNA methyl transferase-1 [21].
A large body of literature suggests that inflammation is largely mediated by activated microglia
in neurodegenerative diseases [22,23]. It has been hypothesized that dietary interventions through the
consumption of foods rich in polyphenols and other antioxidants and anti-inflammatory agents may
prevent the onset of age-related neurodegenerative diseases [24]. However, in spite of their efficacy,
demonstrated by many in vitro studies, single isolated polyphenols have displayed a limited effect
in vivo and in clinical trials, mainly due to low bioavailability and scarce solubility [25,26]. Conversely,
mixed compounds in food sources have unequivocal beneficial effects, and this might be attributed
to additive and even synergistic effects among different polyphenols and other food components,
such as lipids, sterols, vitamins and minerals. Indeed, there is a growing interest in the importance of
assessing the interactions among the various phytochemicals in food, with regard to their effects on
the pathophysiology of the human body. However, relatively few studies have yet taken into account
the potential protective effects of complex matrices of bioactive molecules contained in foods (for a
review see [27]).
Here, we investigated the effects of a polyphenolic extract from the model plant Arabidopsis
thaliana on the inflammatory response in BV2 cells treated with A 25–35 peptide and in an animal
model of AD, i.e., Drosophila melanogaster flies expressing human A 1–42. Arabidopsis thaliana belongs
to the Brassicaceae family and is a model plant widely used in several research fields [28,29]. It grows
quickly in a growth chamber with computer-controlled crucial parameters—quality/quantity of
light, day and night cycles, humidity and temperature—ensuring uniform growth conditions and
composition of the juices. Moreover, Arabidopsis has a fully sequenced and extensively mapped
genome and metabolome [30,31], as well as a large collection of mutants and genetic/molecular tools
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that make metabolic engineering possible, thus representing an appealing system to study the impact
of polyphenolic complex matrices on several human disease models.
2. Results
2.1. Qualitative and Quantitative Analysis of Polyphenols in Arabidopsis Extract
Several authors reported the presence of flavonoid glycoside derivatives and hydroxycinnamoyl
derivatives in Arabidopsis extracts [30,32–34]. To establish the qualitative/quantitative composition
of our extract, Arabidopsis seedlings were grown for seven days and the raw juice obtained by cold
pressure was analyzed by chromatographic or colorimetric methods. As the raw juice may contain
also proteins, minerals, nucleic acids and fibers or chlorophyll that may interfere with polyphenolic
determination, the raw juice was extracted with ethyl acetate (EtOAc) in order to obtain a selective
enrichment in flavonoids.
Chromatographic analyses of an EtOAc extract of raw juice revealed the presence of polyphenols
and flavonoids (Figure 1). Under our chromatographic conditions, the main constituents of the extract
were eluted between 4 and 6 min. Main peaks were identified as polyphenols or flavonoids by
chromatographic behavior, comparison with analytical standards, UV-visible spectra, molecular mass,
molecular formula, and MS/MS fragmentation, and are detailed in Table 1.
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1 * Caffeic acid 180.06 C9H8O4 326 179
2 Quercetin-rhamnoside-hexoside 610.16 C27H30O16 350 609 611 447, 301 449, 303
3 Kaempferol-3-O-glucoside-7-O-rhamnoside 594.16 C27H30O15 351 593 595 431, 285 433, 287
4 Quercetin-di-rhamnoside 594.16 C27H30O15 350 593 595 447, 301 449, 303
5 Isorhamnetin-hexoside-rhamnoside 624.17 C28H32O16 345 623 625 315 463, 317
6 Kaempferol-3, 7-di-O-rhamnoside 578.17 C27H30O14 351 577 579 433, 287
7 * Synapic acid 224.06 C11H12O5 327 223
8–9 di-O-sinapoyl- -glucose (isomers) 592.17 C28H32O14 327 591 367, 349, 223
10 * Luteolin 286.05 C15H10O6 350 285 287
* confirmed by analytical standard injection.
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Results and experimental data are reported in Table 1. Peak 1 was identified as caffeic acid. Peaks
2–3–4–5 and 6 were identified, respectively, as quercetin-exoside-rhamnoside, kaempferol-3-O-glucoside-7-
O-rhamnoside, quercetin-dirhamnoside, isorhamnetin-exoside-rhamnoside and kaempferol-3,7-O-
dirhamnoside. Sinapic acid (peak 7) was identified as the major polyphenolic component of EtOAc
extract. Peaks 8 and 9 were identified as two isomers of 1,2-di-synapoyl-D-glucose. Luteolin (peak 10)
was one of the last eluted compounds, due to its more hydrophobic nature. All our experimental data
reported in Table 1 are in agreement with the known and recent reports in the literature [35,36]. For
the detailed chemical structures of each compound see Figure S1 supplementary materials.
The total content of polyphenols and anthocyanins was estimated by the Folin-Ciocalteau and
pH differential methods, respectively. The analysis revealed that EtOAc selectively extracts the
flavonoidic fraction, while anthocyanins and simple phenolics largely remain in the aqueous layer,
as demonstrated by chromatographic analyses (not shown). Total polyphenols, expressed as mg
GAE/mL, were found to be 0.32 ± 0.02 and 0.10 ± 0.01 for raw juice and EtOAc extract, respectively;
whereas total anthocyanins, expressed as µg CGE/mL, were 0.88 ± 0.05 in raw juice and absent in the
EtOAc extract.
In order to verify whether the antioxidant activity was affected by the EtOAc extraction procedure,
we performed the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay on both the raw juice and the extract
(see Figure S2 supplementary materials). Data revealed that while in the EtOAc extract the antioxidant
activity was linearly related to the amount of extract added, in the raw juice the activity reached a
plateau. These results may be justified by the fact that the DPPH assay is performed in ethanol and
this solvent may cause the precipitation of proteins and other pigments present in the raw juice that
could interfere with spectrophotometric determinations. Based on these observations, all subsequent
experiments were performed using the EtOAc extract.
2.2. The Arabidopsis EtOAc Extract Affects Pro-Inflammatory and Anti-Inflammatory Cytokines Gene
Expression in BV2 Cells
To analyze the inflammatory response, BV2 cells were treated up to 24 h, with 25 µM A 25–35
aggregated peptide in the presence or absence of the EtOAc extract (20 µL/mL), and the expression of
several pro-inflammatory and anti-inflammatory cytokine genes was measured by qRT-PCR. Both the
concentration of A 25–35, as well as the amount of EtOAc extract were chosen based on dose-response
curves and on previous data [37,38]. The effect of different amounts of Arabidopsis EtOAc extract on
BV2 cellular viability was tested up to 50 µL/mL: No cytotoxic effects were observed up to 20 µL/mL,
whereas higher concentrations caused a slight viability decrease (data not shown). Based on these
results, we used a concentration of 20 µL/mL of extract for further experiments.
Figure 2 reports the expression of cytokine genes (IL-6, IL-1b, TNF-a, IL-4, IL-10, IL-13) in control
and treated samples at 2 and 24 h. As shown in Figure 2A–C, at 2 hours, IL-6, IL-1b and TNF-a showed
overexpression in samples treated with 25 µMA 25–35 peptide (about 1.5–2 fold), and an even higher
expression in samples treated with the EtOAc extract or with both A 25–35 peptide and EtOAc extract
compared to control (about 3–4 fold). The statistical analyses indicate that the overexpression was highly
significant, with p < 0.01 vs. control for samples treated with 25 µMA 25–35 peptide and with p < 0.001
vs. control for samples treated with EtOAc extract or with both A 25–35 peptide and EtOAc extract.
After 24 h, pro-inflammatory cytokines gene expression remained steadily high in BV2 cells
treated with A 25–35. Conversely, in cells treated with the EtOAc extract, gene expression reverted to
the level of untreated controls, both in the presence and in the absence of A 25–35. In particular, no
significant differences could be observed between controls and samples treated with either the EtOAc
extract alone or in the presence of A 25–35, whereas the treatment with A 25–35 alone maintained the
expression values of all cytokine genes at around 1.5–2 times higher than control, with p < 0.01 vs.
control. The lower pro-inflammatory cytokine gene expression observed after 24 h in samples treated
with either the EtOAc extract or the extract and A 25–35, was already appreciable after six hours (data
not shown).
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25 µM A 25–35 and/or 20 µL/mL of EtOAc extract, evaluated by qRT-PCR at 2 and 24 h. (A) IL-6
expression; (B) IL-1b expression; (C) TNF-a expression; (D) IL-4 expression; (E) IL-10 expression;
(F) IL-13 expression. Data are shown as mean ± SEM (n = 3). ** p < 0.01 vs. Ctrl; *** p < 0.001 vs. Ctrl.
We also analyzed the anti-inflammatory response, testing the expression of the anti-inflammatory
cytokin genes IL-4, IL-10 and IL-13 (Figure 2C,D,F). After 2 h, no sig ificant differences between control
and sa ples treated with 25 µM A 25–35 could be evidenc d, although there was a slight decre se
of g ne expression. After 24 h, the treatment with A 25–35 peptide gave rise to a significant decrease
of g ne expression in all genes considered, with values of about 0.6 compared to control (p < 0.01).
In samples treated with the EtOAc extract, either alone or in the presence of A 25–35, the expression of
anti-i flammatory cytokine genes increased by about 1.5–2 fold compared to c ntrols at 24 h, while
after 2 h only a non statistically significant in rease was evidenc d, indicating a positive trend.
2.3. The Arabidopsis EtOAc Extract Affects Nrf2 and p65 Nuclear Translocation in BV2 Cells
To elucidate the upstream signaling pathway involved in EtOAc extract-induced upregulation
of anti-inflammatory and downregulation of pro-inflammatory cytokine genes, we focused
on the activation of Nrf2 (nuclear factor E2-related factor 2) and NF-B (nuclear factor
kappa-light-chain-enhancer of activated B cells). We investigated the Nrf2 and p65 (a subunit of
NF-B complex) nuclear translocation by immunofluorescence upon treatment of BV2 cells with the
A 25–35 peptide, with the EtOAc extract, or both compared to untreated cells (Figure 3A). After 2 h
of incubation, most of the Nrf2 and p65 signal in control samples was localized outside the nucleus,
with a nucleus/cytoplasm (n/c) signal ratio of 0.83 ± 0.09 for Nrf2 and 0.57 ± 0.07 for p65 (Figure 3B).
When BV2 cells were treated with 25 µMA 25–35 peptide, a small fraction of Nrf2 translocated into the
nucleus and the n/c signal ratio became 1.18 ± 0.13. Conversely, the n/c signal ratio of p65 raised from
0.57 to 1.37 ± 0.25, indicating a major change in p65 localization and the activation of NF-B-mediated
Int. J. Mol. Sci. 2019, 20, 708 6 of 19
pathways. In cells treated with the EtOAc extract alone or in combination with the A 25–35 peptide,
the nuclear translocation of these proteins was more pronounced: The n/c ratio of Nrf2 raised from
0.83 in the control, to 1.94 ± 0.20 in the former condition and to 2.02 ± 0.15 in the latter; as of p65,
the n/c raised from 0.57 in control samples to 1.05 ± 0.07 and to 1.20 ± 0.07 in samples treated with
the EtOAc extract alone or in combination with the A 25–35 peptide, respectively.Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 7 of 19 
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Int. J. Mol. Sci. 2019, 20, 708 7 of 19
Analysis by fluorescence staining intensity vs. pixel position showed similar results (Figure 3C).
In particular, in control samples the Nrf2 and p65 signal intensity (expressed in arbitrary units—au)
was very low in the nucleus (0.2–0.8 pixel range), but was higher than control in samples treated with
A 25–35, reaching maximum values of 65 au for Nrf2 and 155 au for p65 in the nucleus. Conversely,
in cells treated with the EtOAc extract alone or in combination with A 25–35, the nuclear translocation
of Nrf2 reached maximum values of 250 and 230 au, respectively, whereas p65, was less evident, with
maximum values of 50 and 90 au, respectively.
All in all, these data suggest the activation of the NF-B pro-inflammatory pathway in samples
treated with A 25–35 and the activation of Nrf2 anti-inflammatory pathway in samples treated with
the EtOAc extract alone or in combination with A 25–35.
2.4. The Arabidopsis EtOAc Extract Affects Cellular Antioxidant Defense Capacity and Counteracts Ab25–35
Induced Cytotoxicity
It is well known that the activation of the Nrf2 pathway mediates the activation of a set of
genes that modulate the antioxidant response of the cell. Among these genes two of the most readily
responsive are those encoding the heme oxygenase (HO-1) and the DT-diaphorase (NAD(P)H:quinone
oxidoreductase 1, NQO1). To verify whether the nuclear translocation of Nrf2 activates the antioxidant
cellular response, we determined the mRNA levels of HO-1 by qRT-PCR. Moreover, we tested the
activity of the enzyme NQO1 by means of a specific spectrophotometric assay. As shown in Figure 4A,
in BV2 cells treated with 25 µM A 25–35 for 2 hours HO-1 gene expression showed little change,
compared to untreated controls (1.4-fold increase, not statistically significant), while it showed a
substantial increase in BV2 cells treated with the EtOAc extract alone or in combination with A 25–35
(6.5- and 4.7-fold, respectively; HO-1, p < 0.001 vs. control).
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Figure 4. Modulation of HO-1 expression, NQO1 activity and cellular viability of BV2 cells treated
with 20 µMA 25–35 and/or 20 µL/mL of EtOAc extract. (A) HO-1 expression at 2 h. (B) Measurement
of NQO1 activity at 24 h. (C) Cellular viability at 24 h (% of control). Data are shown as mean ± SEM
(n = 3). * p < 0.05 vs. Ctrl; ** p < 0.01 vs. Ctrl; *** p < 0.001 vs. Ctrl; §§§ p < 0.05 vs. A 25–35.
Measurement of NQO1 activity levels in BV2 cells did not show any effect of A 25–35 treatment
(Figure 4B). Conversely, treatment with the EtOAc extract, either alone or in the presence of A 25–35,
caused a significant increase of the NQO1 activity compared to controls (3.5 and 2 fold, respectively),
pointi g to an antioxidant ffect of the xtract.
In order to confirm a cytoprotective effect of the extract, we a alyzed the viability of BV2 cells by
MTT assay, i the presence of A 25–35, of EtOAc extract and of both. As shown in Figure 4C, 25 µM
A 25–35 treatment significa tly decreased BV2 cells v ability as ompared to untreated cells (65% at
24 h, p < 0.001 vs. c ntrol), while th tr a ment with th EtOAc extract alo e did not affect cell viability
(106% at 24 h, p < 0.001 vs. control). Co-treatment with EtOAc extract and A 25–35 significantly reduced
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A 25–35-induced cytotoxicity (80% at 24 h, p < 0.001 vs. A 25–35), pointing to a protective effect of
the extract.
2.5. The Arabidopsis EtOAC Extract Alleviates the Locomotor Dysfunction Induced by Ab1–42 in Drosophila
melanogaster
In order to study the neuroprotective and therapeutic potential of the complex mixtures of
polyphenols in vivo, we evaluated the climbing ability of transgenic AD flies expressing human A 1–42
fed on standard medium supplemented with polyphenolic extract (Figure 5). In our experiments,
the glial-specific expression of the human pathogenic construct (A 1–42) under the control of UAS
(Upstream Activator Sequence) elements was achieved by using the pan-glial driver repo-Gal4 [39].
AD flies expressing A 1–42 were allowed to feed on the diet supplemented with the EtOAc extract
(40 µL/mL in standard sugar-yeast medium) for the entire developmental period and then assayed for
climbing activity at 3–5 and 10–12 days post-eclosion. The results obtained showed that the EtOAc
extract significantly ameliorates impaired climbing ability of A 1–42 flies when compared to untreated
control flies, confirming that the Arabidopsis polyphenolic extract exerts a neuroprotective effect also
in vivo.
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Figure 5. Alzheimer’s disease (AD) flies expressing A 1–42 in glial cells using the repo-Gal4 driver
were allowed to feed on the diet supplemented with EtOAc extract (40 µL/mL in standard sugar-yeast
medium) for the entire developmental period and then assayed for climbing activity at 3–5 and
10–12 days. Climbing abilities are presented as the average performance index (PI) ± SEM. * p < 0.05.
3. Discussion
The inflammatory response of the brain is mediated by its resident microglia which becomes
“activated” when a noxious stimulus hits the brain [22]. Neuroinflammation is initially a protective
defense mechanism against injuries or infective agents. In AD brains, A  induces increased production
of pro-inflammatory cytokines, such as IL-1 , TNF-↵ and IL-6, which have been demonstrated to cause
neuronal toxicity and death [40]. The production of pro-inflammatory cytokines, while having some
beneficial effect by ameliorating amyloid deposition, can induce an “autotoxic loop” and enhance
tau pathology and neurodegeneration [22]. Based on these observations, it has been proposed that
anti-inflammatory drugs may have a therapeutic role in AD. A large body of literature supports the
efficacy of NSAIDs in counteracting A  toxicity and production, however, clinical trials in AD patients
failed to evidence any beneficial effect [23].
The use of polyphenols has been proposed as an alternative valid strategy to dampen
inflammatory processes in early AD, and therefore to reduce AD severity. These natural compounds
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are abundantly present in some foods and, more importantly, food matrices contain mixtures of
different polyphenols and flavonoids, which can have additive or even cooperative effects.
Recently, we demonstrated that juices from Brassica oleracea sprouts, containing a complex mixture
of polyphenols, are able to protect neuronal cells in culture from the deleterious effects of A 25–35,
through antioxidant mechanisms mediated by the activation of the nuclear factor Nrf2 [41]. The juices
derived from edible plants, such as Brassica oleracea, hardly represent the ideal tool to understand
how a bioactive compound acts, or how several bioactive molecules interact, in affecting a biological
process. Indeed, the domestication of plants resulted in changes to several traits and reduced the
genetic variability for several other: In particular healthy bitter components, like many flavonoids
or mustard oil components, have been strongly reduced or even eliminated by breeding practices.
Most wild plant species, including Arabidopsis thaliana, show a solid intraspecific natural variation
for several properties involved in adaptation to different environmental growth conditions (for a
review see [42]). Each of the about 7000 wild type Arabidopsis accessions collected and available
in the stock center [43] may be characterized by a different polyphenolic profile as suggested by
Routaboul et al. [44]. Moreover, Arabidopsis thaliana can be grown in growth chambers under strictly
controlled environmental conditions (light, temperature, humidity etc.). As growth conditions do
affect the production of secondary metabolites, varying Arabidopsis growth parameters allow to
reproducibly modify the polyphenolic content of this plant. Furthermore, the genome of Arabidopsis
is completely sequenced and extensively mapped, and a large collection of mutants, as well as a vast
arsenal of genetic/molecular tools are available, making metabolic engineering feasible.
Here, we investigated the efficacy of complex polyphenolic mixtures as anti-inflammatory agents
in a cellular model of inflammation in AD, i.e., BV2 murine microglial cells stimulated with A 25–35 in
the presence or absence of a polyphenolic extract from Arabidopsis thaliana seedlings.
Polyphenol-containing juice was obtained by cold pressure of seedlings grown for seven days.
The choice of this starting material was based on the observation that seedlings usually contain
much higher amounts of bioactive and protective compounds per gram of fresh weight than adult
plants. Cold pressure was performed to limit auto-oxidation of the phenolic compounds, due to high
temperature. Before proceeding to the qualitative analysis of the Arabidopsis extract by UPLC-MS-MS
and test them on the cellular and animal models of AD, we enriched the extract in the flavonoidic
fraction by extraction with EtOAc. This procedure also allowed us to eliminate proteins, minerals,
nucleic acids and fibers or chlorophyll which could affect the interpretation of results. The analysis of
phenolics, performed in both raw juices and purified EtOAc extract, revealed the presence of caffeic
acid, kaempferol and quercetin derivatives, along with sinapic acid and its derivatives. These results
indicate that the Arabidopsis seedling juice has a polyphenolic content similar to that of seeds or of
several tissues of adult plants [30,36].
By using this EtOAc extract, we assessed the gene expression profile of pro-inflammatory and
anti-inflammatory cytokines following A  treatment in the presence or absence of the EtOAc extract
in the short and in the long term. The expression of genes encoding anti-inflammatory cytokines
(IL-4, IL-10, IL-13) was downregulated following A  treatment, whereas it was upregulated when the
phenolic extract was used -either alone or in the presence of A 25–35, pointing to an action of these
compounds against the effects of A 25–35. Conversely, the expression of pro-inflammatory cytokines
(IL-6, TNF-a, IL-1b) increased when the cells were treated with A 25–35, whereas the effect of the
EtOAc extract was less linear. In fact, in the short term the extract seemed to enhance the expression
of the cytokines, while in the long term it restored the expression to control levels. Apparently, in
the short term the extract is able to activate an inflammatory response which is already reverted at
six hours, leading to a suppression of the inflammatory pathway in the long term which contrasts
amyloid action. These data may be best interpreted in light of recent evidence which indicates that
the production of pro-inflammatory cytokines plays a pivotal role in neurodegeneration, but also
in neuroprotection [45]. Indeed, microglia are able to exert either neuroprotective or neurotoxic
effects depending on its activation state. Notably, microglia could assume a “classically activated”
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state, termed M1 (a definition borrowed from the activated macrophage states), which is induced
by the presence of TNF-↵ or INF  produced by T-cells or natural killer cells, and displays a high
defense profile against pathogens by acidifying the phagosome and releasing ROS/RNS. Conversely,
the activation state M2, which results from stimulation of glia by IL-4 and -13, or by IL-10, gives rise to
wound healing or anti-inflammatory type microglia. The delicate balance between these two activation
states drives the evolution of the neurodegenerative disease. The M1 state is not dangerous per se, but
could rather play a defense role in the first phases of the disease. However, if the activation of the M1
state persists and is not replaced by M2 state microglia, the prolonged inflammatory stimulus results
in a deleterious effect and tissue damage [46].
The production of cytokines is under the control of a signal transduction circuit involving
the Nrf2 and NF-B nuclear factors. Nrf2 is a transcription factor that regulates the expression
of antioxidant genes that protect against oxidative damage, injury and inflammation by stimulating
the anti-inflammatory cytokine genes and antioxidant or phase II detoxification enzymes. This
transcription factor is activated by various compounds present in Brassicaceae, such as polyphenols
and glucosinolates [47]. Conversely, NF-B, a protein complex formed by p65 and p50 subunits, is
involved in pro-inflammatory processes and cell death. The stimulation of BV2 cells by A 25–35, either
alone or in combination with the EtOAc extract, causes nuclear translocation of both Nrf2 and NF-B
p65 subunit within two hours of treatment. In particular, both factors are barely detected at the nuclear
level in control cells, whereas under A 25–35 treatment there is a massive translocation of p65 and
a slight translocation of Nrf2. Under polyphenol treatment or co-treatment, Nrf2 translocation is
very evident while p65 is still appreciable. The simultaneous presence of Nrf2 and NF-B p65 in the
nucleus when the cells are stimulated with polyphenols, either alone or in the presence of A 25–35,
could be the driving force that stimulates the large expression of the pro-inflammatory cytokines
within the short term. According to [48,49], the promoters of pro-inflammatory cytokine genes contain
responsive elements for both p65 and Nrf2. However, in the long term the equilibrium is in favor
of an anti-inflammatory profile. This shift could be due to an indirect inhibitory effect of Nrf2 on
pro-inflammatory cytokines production exerted through the binding to the promoter(s) of alternative
genes or to the action of other transcription factors [48].
In short, while in A 25–35-treated cells the NF-B pro-inflammatory pathway is prevalent, the Nrf2
anti-inflammatory pathway is predominant in cells co-treated with A 25–35 and the EtOAc extract
or treated with this latter alone. This view is supported by viability data and by the modulation of
the expression of genes directly under the control of the Nrf2 pathway, i.e. HO-1 and NQO1. Indeed,
cell viability is restored to levels similar to control, and the expression of HO-1 and the activity of
NQO1 are positively regulated, when the cells are co-treated or treated with the EtOAc extract, and the
expression of HO-1 and the activity of NQO1 is positively regulated, whereas both enzymes remain
unaltered when the cells are treated with A 25–35 alone.
In order to confirm the efficacy of the extract in vivo, we performed an experiment in an
animal model of AD, i.e. Drosophila melanogaster flies expressing the human A 1–42 peptide at the
glial level. Drosophila offers a powerful in vivo model to study the A -induced toxicity, because
transgenic expression of the human pathogenic fragment of APP (A 1–42) recapitulates the majority of
pathological hallmarks of AD, including neurotoxicity, nuclear inclusion formation, age-dependent
neurodegeneration, locomotor dysfunction and early death [50–54]. The Drosophila AD model has
been studied to evaluate the protective effects of selected polyphenols as reported in the comprehensive
review by Del Rio and Pardo [55]. For instance, beneficial effects of quercetin are mediated by a protein
associated with the cell cycle pathway in the Drosophila AD model driving Arctic A 1–42 expression
in the brain [56], whereas Drosophila transgenes fed with curcumin showed a lower A  neurotoxicity,
due to an acceleration of amyloid fibril conversion [57]. Moreover, AD flies treated with kaempferol
showed a delay of climbing ability loss, a rescue of memory and reduced oxidative stress [58]. In our
model of transgenic AD flies expressing human A 1–42, feeding on standard medium supplemented
with polyphenolic extract resulted in a significant improvement of the impaired climbing ability of
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AD flies, confirming the neuroprotective effect of the EtOAc extract, also in vivo. These observations
also corroborate the notion that in this extract different polyphenols act synergistically and better
recapitulate the food content.
4. Materials and Methods
4.1. Chemicals
Unless otherwise stated, reagents were purchased from Sigma Aldrich (St. Louis, MO, USA).
A 25–35 was synthesized by conventional solid phase chemistry [59]. Other reagents were: Trizol
reagent from Invitrogen (Carlsberg, CA, USA); QuantiTect Reverse Transcription kit from QIAGEN
(Hilden, Germany); primary antibody rabbit monoclonal anti-Nrf2 and secondary antibody goat
polyclonal anti-rabbit IgG (Alexa Fluor® 488) were from Abcam (Cambridge, UK); mouse monoclonal
anti-NFB p65 subunit was from Cell Signaling Technology (Milan, Italy); and anti-mouse IgG (Texas
Red) Jackson Immunoresearch Laboratories (West Grove, PA, USA). Tissue culture medium and serum
were from Gibco BRL (Life Technologies Inc., Grand Island, NY, USA)
4.2. Plant Growth and Juice Preparation
Wild-type early flowering Arabidopsis thaliana from Columbia-0 (Col-0) ecotype was used in this
work. All plants were grown in a growth chamber at 24/21  C with a light intensity of 300 µE·m 2·s 1
under 16 h light and 8 h dark per day. Seeds were surface sterilized with a 2.5% aqueous solution
of INOV’chlore (Inov Chem) for 10 min and then rinsed four times with sterile water. After five
days of cold treatment, Arabidopsis thaliana seeds were plated on one-half MS (Murashige and Skoog
medium, Duchefa) and grown in a climate chamber for seven days. The seedlings were collected
and cold-pressed for the production of raw juice. The juice obtained was centrifuged at 12,000⇥ g for
10 min at 4  C. The supernatant was immediately frozen in liquid nitrogen and stored at  80  C until
use. 2 mL aliquots were extracted four times with an equal volume of EtOAc. Upper organic phases
derived from extractions where combined and divided in 20 aliquots (each corresponding to 100 µL of
original extract) in 2 mL propylene microtubes. Vials were then dried under vacuum and each aliquot
resuspended in complete culture medium to obtain a final concentration corresponding to 20 µL of
original extract per mL of culture medium. Before treating the cells, the diluted extract was filtered on
a 0.2 µm sterile cellulose acetate membrane.
4.3. Determination of Total Phenols and Anthocyanins
Total reductants (mostly phenols) were determined by the Folin-Ciocalteu assay as described by
Singleton et al. [60]. Briefly, the reaction solution was prepared by mixing 10 µL of blank, standard
or sample with 790 µL of distilled water. After addition of 50 µL Folin-Ciocalteu reagent the reaction
mixture was incubated for 3 min at room temperature (RT) and then 150 µL of a 20% (w/v) Na2CO3
aqueous solution were added. After 2 h of incubation, the absorbance at 760 nm was measured on a
Hitachi U2000 spectrophotometer (Hitachi, Tokyo, Japan). The results were expressed as mg of gallic
acid equivalents (GAE) per mL of juice.
Total anthocyanins quantification was performed by the pH-differential method as described by
Giusti andWrolstad [61]. The juice was diluted in a pH 1.0 solution (0.1MHCl, 25 mMKCl) and in a pH
4.5 solution (0.4 M CH3COONa). The absorbance of the mixtures was then measured at 535 and 700 nm
against distilled water. The value (Abs535   Abs700)pH 1.0   (Abs535   Abs700)pH 4.5 corresponds
to the absorbance, due to the anthocyanins. Calculation of the anthocyanin concentration was based
on a cyanidin-3-O-glucoside (Cy-3G) molar extinction coefficient of 25,965 M 1·cm 1 and a molecular
mass of 449.2 g·mol 1. Results were expressed as µg cyanidin-3-O-glucoside equivalents (CGE) per mL
of juice.
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4.4. Chromatography and Mass Spectrometry
LC-DAD-MS determination of polyphenols was performed on a Waters Acquity H-Class UPLC
system (Waters, Milford, MA, USA), including a quaternary solvent manager (QSM), a sample manager
with flow through needle system (FTN), a photodiode array detector (PDA) and a single-quadruple
mass detector with electrospray ionization source (ACQUITY QDa). Chromatographic analyses were
performed on a Waters C18 HSST3 column (100 mm ⇥ 2.1 mm i.d., 1.7 µm particle size). PDA detector
was set up in the range of 200 to 600 nm. Mass spectrometric detection was set in the negative
electrospray ionization mode using nitrogen as nebulizer gas. Analyses were performed in Total Ion
Current (TIC) mode in a mass range 50–1000 m/z. Capillary voltage was 0.8 kV, cone voltage 30 V, ion
source temperature 120  C and probe temperature 600  C.
LC-HR-MS/MS (High Resolution TandemMass Spectrometry) measurements were performed
on a Dionex Ultimate 3000 UHPLC System, equipped with a quaternary pump, autosampler (100 µL
sample loop, partial injection mode, 2 µL injection volume, sample temperature 8  C), a photodiode
array detector (PDA) (Thermo Fisher Scientific, Bremen, Germany). The effluent from PDA detector
was connected on-line to an LTQ-Orbitrap Elite mass spectrometer equipped with a high-temperature
electrospray ionization (HESI) ion source, controlled by the Excalibur 2.7 software (Thermo Fisher
Scientific, Bremen, Germany) and operated in the negative or positive ion mode. The ion spray voltage
was set to 4.0 kV, sheath and auxiliary gases on 20 and 5 psi, respectively. The Orbitrap-MS spectra
were acquired at the m/z range of 50–2000 with a resolution of 30000. The tandem mass spectra were
acquired by collision induced dissociation (CID) in linear ion trap (LIT) at 35% normalized collision
energy and isolation width of 2.0 m/z. The fragments were detected at the FT-resolution of 30000.
For both LC systems, the same chromatographic method was used. Solvent A was 0.1% aqueous
HCOOH and solvent B was 0.1% HCOOH in CH3CN. The flow rate was 0.5 mL/min and the column
temperature was set at 25  C. Elution was performed isocratically for the first minute with 2% B;
from min 1 to min 6 solvent B was linearly increased to 55%; from min 6 to min 10 elution was
isocratic with 20% A and 80% B; then, in 0.5 min solvent B was set at 100% and maintained for
two minutes. The column was re-equilibrated with 98% A and 2% B before the next injection. An
aliquot of the extract dried under vacuum was resuspended in 100 and 10 µL injected through the
needle. The identity of the compounds of interest was established by using analytical standards and
by combining chromatographic behavior, UV-Vis spectral data, mass spectrometric results and mass
fragmentation patterns.
4.5. DPPH Free Radical Scavenging Assay
An aliquot of 10 µL of diluted juices in ethanol (0–10 µL/mL final concentration) was added to
1 mL of 30 µM ethanolic solution of stable nitrogen centered free radical 2,2-diphenyl-1-picrylhydrazyl
(DPPH•) and the absorbance was monitored spectrophotometrically at 517 nm after 15 min at RT.
Radical DPPH• scavenging capacity was estimated from the difference in absorbance with or without
antioxidants and expressed as percent DPPH• disappearance as a function of the sample concentration.
4.6. Preparation of Ab25–35 Stock Solution
A 25–35 was dissolved in sterile phosphate buffered saline, pH 7.4 (PBS) at a concentration of
1 mM and incubated in a sonicator bath on ice for 30 min to induce aggregation. After treatment,
the solution was incubated overnight at 37  C and then stored at  20  C until use. Immediately before
treating the cells, the stock solution was diluted to 25 µM final concentration in culture medium.
4.7. Cell Culture and Treatment
BV2 (microglial) cells were a kind gift of Prof. Cinzia Fabrizi. Cells were grown in DMEM/F-12
medium containing 10% fetal bovine serum (Gibco BRL Life Technologies Inc., Grand Island, NY,
USA) and 2 mM L-glutamine at 37  C in a humidified atmosphere with 5% CO2. Cells were plated
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at an appropriate density according to each experimental setting and treated with 25 µM aggregated
A 25–35 in the presence or in the absence of 20 µL/mL of extract reconstituted in DMEM/F12. Cells
treated only with EtOAc extract were run in parallel. Untreated cells were used as a control.
4.8. Cell Viability Assay
Cell viability was determined by using thiazolyl blue tetrazolium bromide (MTT) dye reduction
assay. Briefly, cells were seeded in 96-well plates at a density of 3000 cells/well. After treatment, 20 µL
of a 5 mg/mL solution of MTT in PBS was added to the culture medium and cells were incubated at
37  C for 2h. The supernatants were then aspirated off and formazan crystals were dissolved with
100 µL/well of dimethyl sulfoxide. The optical density of each well was determined at 570 nm with a
reference at 690 nm using a microplate reader (Appliskan microplate reader, Thermo Scientific, Vantaa,
Finland).
4.9. qRT-PCR
Total RNA for reverse transcription-polymerase chain reaction (RT-PCR) was extracted using
Trizol reagent according to manufacturer’s instructions. Reverse transcription was performed from
1 µg of total RNA using the QuantiTect Reverse Transcription kit as recommended by the manufacturer.
Real-time quantitative RT-PCR (qRT-PCR)measurements were performed using anApplied Biosystems
7300 Real-Time PCR System, using ribosomal protein S27a (RPS27A) housekeeping gene as normalizing
control. The genes of which we evaluated expression levels were heme oxygenase-1 (HO-1), interleukin
6 (IL-6), interleukin 1-  (IL-1b), TNF-↵ (TNF-a), interleukin 4 (IL-4), interleukin 10 (IL-10) and
interleukin 13 (IL-13). For this purpose, we chose primers designed with GenScript Real-time PCR
Primer Design Software and listed in Table 2.




Heme oxygenase-1 (HO-1) AGGAGGTACACATCCAAGCC TACAAGGAAGCCATCACCAG
Interleukin 6 (IL-6) AAGCTGGAGTCACAGAAGGAG GGTTTGCCGAGTAGATCTCAA
Interleukin 1-  (IL-1b) TTCGTGAATGAGCAGACAGC CCATGGTTTCTTGTGACCCT
TNF-a TGGCCTCTCTACCTTGTTGC GGGAGCAGAGGTTCAGTGAT
Interleukin 4 (IL-4) TGTACCAGGAGCCATATCCA TTCTTCGTTGCTGTGAGGAC
Interleukin 10 (IL-10) CCCAGAAATCAAGGAGCATT TCACTCTTCACCTGCTCCAC
Interleukin 13 (IL-13) AGCATGGTATGGAGTGTGGA TTGCAATTGGAGATGTTGGT
Ribosomal protein S27a (RPS27A) AGAGGCTGATCTTTGCTGGT ACCAGATGAAGGGTGGACTC
The amplifications of qRT-PCR were monitored using the SYBR Green fluorescent stain and the
presence of a single PCR product was verified by melting curves in all amplifications. The comparative
threshold cycle (DDCt) methodwas used to calculate the relative amount of gene expression. The values
were normalized with the control and the propagated standard deviations were calculated.
4.10. NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Activity
Cells were seeded in 75 cm2 flask at a density of 1.5 ⇥ 106 cells/flask. After treatment,
the cells were washed with PBS and lysed in 250 µL of ice-cold 20 mM Tris-HCl buffer (pH 7.4)
containing 250 mM sucrose, 1 mM phenylmethanesulfonyl fluoride and CIP 50⇥, SigmacOmplete
Protease Inhibitor Cocktail by using the Potter-Elvejham homogenizing system. The homogenate was
centrifuged at 15,000⇥ g for 20 min at 4  C. NQO1 activity was carried out as previously described [62].
Briefly, the reaction mixture (1 mL) contained 50 mM sodium phosphate buffer (pH 7.4), 0.7 mg/mL
bovine serum albumin (BSA), 40 µM 2,6-dichlorophenolindophenol (DCPIP), and 40 µg sample
proteins. The reaction was started by adding nicotinamide adenine dinucleotide phosphate reduced
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form ( -NADPH) at a final concentration of 0.3 mM. The decrease in absorbance, due to the reduction
of DCPIP, was monitored at 600 nm during the first 10 s of the kinetics. Unspecific activity was
determined by adding 10 µM dicoumarol to the reaction mixture before addition of  -NADPH and
subtracted to total activity. NQO1 activity was calculated as nmol of reduced DCPIP per min per mg
of total protein by using an extinction coefficient of 21 ⇥ 10 3 M ⇥ cm 1. The intracellular NQO1
activity levels were expressed as a percentage compared to control cells.
4.11. Nrf2 and NF-kB Immunofluorescence
Cells were seeded on 18⇥ 18 mm glass coverslips in 6-well plates at a density of 5⇥ 105 cells/well.
After treatment the cells were fixed by incubating with 2% (w/v) formaldehyde in PBS, washed and
permeabilized with 0.1% (v/v) Triton X-100 in PBS. After washing with PBS, the coverslips were
exposed for 30 min to blocking buffer (5% (w/v) BSA in PBS) and then incubated overnight at 4  C
with the rabbit anti-Nrf2 mAb (1:100 dilution) and with the mouse anti-NF-B p65 subunit mAb (1:100
dilution) in 1% (w/v) BSA in PBS. The coverslips were washed with PBS before incubation for 1 h
with the secondary antibody Alexa Fluor® 488 goat anti-rabbit IgG (1:500 dilution) and with Texas
Red goat anti-mouse IgG (1:100 dilution) in 1% (w/v) BSA in PBS. Nuclei were stained for 1 min
with 1 µg/mL of 40,6-diamidino-2-phenylindole dihydrochloride (DAPI) in saline solution and the
coverslips were mounted with Mowiol. Fluorescence signal was analyzed by recording stained images
using an AxioObserver inverted microscope, equipped with the ApoTome System (Carl Zeiss Inc.).
Microscopy imaging was performed using the Axiovision software (Zeiss).
To analyze the Nrf2 and NF-B nuclear translocation by immunostaining assay, ImageJ software
was used, and three fields were analyzed for each sample. The average of signal quantification was
obtained by the ratio between mean grey value for each nucleus and cytoplasm after subtraction of








where the nucleus is the mean grey value for each nucleus measured for each nucleus, cytoplasm is
the mean grey value measured for each cytoplasm, bk features the mean of background signals and
N = 50. The errors were calculated as propagated standard deviations.
4.12. Fly Stocks and Crosses
Transgenic fly lines that express wild-type human amyloid 1–42 (w1118;
P{UAS-APP.A 42.B}m26a #33769) and a pan-glial repo-Gal4 driver (w1118; P{GAL4}repo/TM3, Sb1
#7415) were obtained from Bloomington Drosophila Stock Center (Indiana University, Bloomington,
IN). The Ore-R stock used here has been kept in our laboratory for many years.
Briefly, repo-Gal4 virgin females were crossed to Ore-R control flies or A 42 flies at 29  C.
The progeny from these crosses were allowed to feed on the diet supplemented with Arabidopsis
EtOAc extract (40 µL/mL in standard sugar-yeast medium) for the entire developmental period. For
control food, EtOH alone was added.
4.13. Climbing Assay
The climbing assay was performed as described in Feiguin and coworkers [63]. Briefly, a group
of 10 flies were placed in an empty vial. A horizontal line was drawn 8 cm above the bottom of the
vial. The number of flies per group that can climb above the 8 cm mark by 15 seconds after the tap was
recorded as the percentage success rate. Ten trials were performed for each group and approximately
100 flies were assayed for each genotype at two time points (at 3–5 days and 10–12 days post-eclosion).
All average data are presented as mean± SEM and compared with 2-tailed unpaired t-tests. Statistical
tests were performed using Prism (GraphPad Software, Inc.). All behavioral studies were performed
at 25  C.
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4.14. Statistical Analysis
Experiments were repeated at least in triplicate and all the results are expressed as the mean value
± standard error of the mean (SEM). Statistical comparison between groups was made using unpaired
Student’s t-test. p values < 0.05 were regarded as significant.
5. Conclusions
Our data support the evidence that an Arabidopsis thaliana extract rich in phenolic compounds
exert anti-inflammatory activity through the activation of the Nrf2 pathway. This evidence further
underlines the importance of correct nutrition as pointed out by epidemiological studies indicating that
a diet rich in fruits, vegetables and spices may afford protection against neurodegeneration. Clinical
studies employing anti-inflammatory drugs in AD probably failed to succeed, because the treatment
was started when the patients already were in an advanced state of the disease. The nutritional
approach may circumvent this problem as supplementation with polyphenols may start even at a
young age long before disease onset, allowing both prevention and a delay in disease progression,
and supporting drug treatment with standard therapeutic approaches. Taken together, our results
open the possibility that the Arabidopsis thaliana extract might be useful in the treatment of pathologies
that involve chronic inflammation in more complex organisms, such as a mouse, which is one of the
most widely used systems to study cellular and molecular bases of human neurodegenerative diseases.
Therefore, the anti-inflammatory activity of the polyphenolic extract from Arabidopsis thaliana needs
to be explored further in additional in vivo studies to provide a possible strategy to modulate an
inflammatory response in the CNS.
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HO-1 Heme Oxygenase 1
NFB Nuclear factor kappa-light-chain-enhancer of activated B cells
NQO1 NAD(P)H:Quinone oxidoreductase 1
Nrf2 Nuclear factor E2-related factor 2
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ROS Reactive oxygen species
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